FDA Clears Avatar Medical Vision for 3D Imaging and Surgical Planning
The software supports CT and MR image visualization across standard displays, glasses-free 3D systems, and virtual reality environments.
The software supports CT and MR image visualization across standard displays, glasses-free 3D systems, and virtual reality environments.
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The cleared system introduces photon-counting CT designed to capture spectral data in a single scan and reduce protocol complexity.
The SIGNA portfolio includes a helium-free 1.5T system, advanced 3T scanner, and AI-driven workflow platform designed to improve imaging efficiency.
The agency exceeded its three-month termination timeline for 74% of recalls during fiscal years 2020-2024, due to staff constraints that limited oversight activities, the report finds.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.